Company intelligence / Profile preview

Atlantic Healthcare

Saffron Walden, United Kingdomatlantichealth.org ↗

Ownership: Private
Development stage: Commercial

Overview

Atlantic Healthcare owns two lead candidate drugs with validated mechanisms: alicaforsen, an antisense oligonucleotide targeting ICAM-1 with anti-inflammatory effects for GI inflammatory diseases, and renzapride, a small molecule serotonin receptor modulator aimed at GI motility disorders. Both drugs are at or near clinical Phase 2/3 development, targeting unmet patient needs in rare GI diseases. Alicaforsen had orphan drug status in the US and a history of clinical development for inflammatory bowel diseases.

Therapeutic areas: GastroenterologyNeurology
Modalities: Antisense oligonucleotideSmall molecule
Industry: Biotech

Drug pipeline

1 asset

alicaforsen

Partnerships

Plans to partner with established pharmaceutical companies for commercialization outside Europe and the U.S. No major pharma partnerships publicly disclosed yet

Beyond the preview

Go deeper on Atlantic Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atlantic Healthcare.

Explore the full profile